Patient selection: hematopoietic stem cell transplant, age >= 18 years
Outcome: 30-day readmission.
Occurrence: 12% for autologous, 24% for allogeneic
Reasons for readmission included:
(1) infection
(2) neutropenic fever
(3) gastrointestinal adverse effects
(4) acute renal failure
(5) dehydration with hypovolemia
(6) graft-vs-host disease (for allogeneic HCT)
Risk factors for readmission after autologous HCT:
(1) age < 50 years
(2) female sex
(3) disease other than myeloma, lymphoma or Hodgkin's disease
(4) Elixhauser co-morbidity score >= 20
(5) short length of stay for index hospitalization
(6) transplant at a low or medium volume center (< 187 vs >= 187 per year)
Risk factors for readmission after allogeneic HCT:
(1) stem cells from cord blood
(2) Elixhauser co-morbidity score >= 10
(3) transplant at a low or medium volume center (< 157 vs >= 157 per year)
(4) ALL
